Global Oncology Leadership Team

Comprised of Takeda's global oncology commercial operations, Takeda Oncology operates in close alignment with Takeda's dedicated global oncology R&D function, the Oncology Therapeutic Area Unit (OTAU) and Takeda's Oncology Drug Discovery Unit to drive forward the company's products while maintaining a focus on expanding our oncology pipeline.

The organizational structure and governance model for Takeda Oncology is designed to drive customer proximity, nimbleness, agility and accountability. Consistent with these principles, Takeda Oncology operates with a relatively flat organization that allows close proximity to our patients and customers, so that we can deeply understand their unique and changing needs and address them.

The Takeda Oncology organization is comprised of the following functions and led by the following individuals:

  • Christophe Bianchi, M.D.
    CHRISTOPHE BIANCHI, M.D.
    President, Global Oncology Business Unit
  • Alessandro 'Miller' Bocalon
    ALESSANDRO "MILLER" BOCALON
    Head, Human Resources, Global Oncology Business Unit & Boston Corp Functions
  • Jim Coccia
    JIM COCCIA
    Vice President, U.S. Market Access
  • Ryan Cohlhepp
    RYAN COHLHEPP
    Vice President, U.S. Marketing, Operations & Analytics
  • Fabien Dubois
    FABIEN DUBOIS
    Head, Finance, Global Oncology Business Unit
  • Shawn Goodman
    SHAWN GOODMAN
    Head, Takeda Boston and Global Oncology Communications
  • Liz Lewis
    LIZ LEWIS
    Chief Counsel, Global Oncology Business Unit and Head, Patient Advocacy
  • Tsudoi Miyoshi
    TSUDOI MIYOSHI
    Head, Japan Oncology Business Unit
  • Liviu Niculescu
    LIVIU NICULESCU, M.D., Ph.D.
    Vice President, Oncology Global Medical Affairs
  • Rosa Notaroberto
    ROSA NOTAROBERTO
    Vice President, U.S. Operations
  • Kelly Page
    KELLY PAGE
    Vice President, Strategic Planning & Global Brand Head, ADCETRIS
  • Fred Paster
    FRED PASTER
    Vice President, Global PMAHE (Pricing, Market Access & Health Economics), Pipeline, and Planning
  • Joe Regan
    JOE REGAN
    Vice President, U.S. Sales
  • Phil Rowlands
    PHIL ROWLANDS
    Head, Oncology Therapeutic Area Unit
  • Latarsha Stewart
    LATARSHA STEWART
    Head, Compliance, Global Oncology Business Unit
  • Dion Warren
    DION WARREN
    Head, Europe Oncology Business Unit